Furthermore, Lie et al. [125] found that ATAD2 is engaged in the CRNDE-mediated miR-126-5p/ATAD2 axis, in which the long noncoding RNA CRNDE suppresses miR-126-5p, increasing ATAD2 expression and elevating paclitaxel resistance in CRC cells [125]. This evidence concerns the gene ATAD2 and colorectal carcinoma.